Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$91.95+0.37 (+0.40%)
Close on Nov 17, 2026Market cap $5.97BP/E –Yield –
Mirum Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Mirum Pharmaceuticals's total assets was $1.04B at Jun 30, 2026. For fiscal 2025 it was $842.81M, up 25.7% from the year before. The highest annual figure on record is $842.81M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $842.81M | +25.7% |
| FY2024 | Dec 31, 2024 | $670.75M | +3.7% |
| FY2023 | Dec 31, 2023 | $646.62M | +83.2% |
| FY2022 | Dec 31, 2022 | $352.91M | +19.8% |
| FY2021 | Dec 31, 2021 | $294.65M | +22.3% |
| FY2020 | Dec 31, 2020 | $240.86M | +64.2% |
| FY2019 | Dec 31, 2019 | $146.71M | +182.3% |
| FY2018 | Dec 31, 2018 | $51.98M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.04B | +44.0% |
| Q1 FY2026 | Mar 31, 2026 | $890.92M | +29.1% |
| Q4 FY2025 | Dec 31, 2025 | $842.81M | +25.7% |
| Q3 FY2025 | Sep 30, 2025 | $785.12M | +17.6% |
| Q2 FY2025 | Jun 30, 2025 | $725.83M | +9.8% |
| Q1 FY2025 | Mar 31, 2025 | $690.25M | +5.9% |
| Q4 FY2024 | Dec 31, 2024 | $670.75M | +3.7% |
| Q3 FY2024 | Sep 30, 2024 | $667.89M | +2.7% |
| Q2 FY2024 | Jun 30, 2024 | $660.75M | +49.0% |
| Q1 FY2024 | Mar 31, 2024 | $651.96M | +84.7% |
| Q4 FY2023 | Dec 31, 2023 | $646.62M | +77.5% |
| Q3 FY2023 | Sep 30, 2023 | $650.64M | +118.9% |
| Q2 FY2023 | Jun 30, 2023 | $443.59M | +59.5% |
| Q4 FY2022 | Dec 31, 2022 | $352.91M | +19.8% |
| Q3 FY2022 | Sep 30, 2022 | $364.35M | +54.9% |
| Q2 FY2022 | Jun 30, 2022 | $297.23M | +20.0% |
| Q1 FY2022 | Mar 31, 2022 | $278.15M | +25.2% |
| Q4 FY2021 | Dec 31, 2021 | $294.65M | +22.3% |
| Q3 FY2021 | Sep 30, 2021 | $235.17M | +65.8% |
| Q2 FY2021 | Jun 30, 2021 | $247.67M | +59.0% |
| Q1 FY2021 | Mar 31, 2021 | $222.24M | +28.6% |
| Q4 FY2020 | Dec 31, 2020 | $240.86M | +64.2% |
| Q3 FY2020 | Sep 30, 2020 | $141.87M | -10.4% |
| Q2 FY2020 | Jun 30, 2020 | $155.77M | +49.4% |
| Q1 FY2020 | Mar 31, 2020 | $172.80M | +232.5% |
| Q4 FY2019 | Dec 31, 2019 | $146.71M | – |
| Q3 FY2019 | Sep 30, 2019 | $158.27M | – |
| Q2 FY2019 | Jun 30, 2019 | $104.27M | – |
| Q4 FY2018 | Dec 31, 2018 | $51.98M | – |
See a number that looks wrong?